Literature DB >> 11131748

Visual evoked potentials under luminance contrast and color contrast stimulation in glaucoma diagnosis.

F K Horn1, A Bergua, A Jünemann, M Korth.   

Abstract

PURPOSE: To evaluate the diagnostic value of visual evoked potential (VEP) assessment with luminance-contrast and color-contrast stimulation in the detection of glaucoma. PATIENTS AND METHODS: The study included 59 patients (96 eyes) with glaucomatous changes of the optic disc and visual field defects and 58 control eyes of 29 healthy patients. Four types of pattern VEP stimulation (0.9 cycle/degree) were performed in all patients: achromatic, alternating sine-wave stripe pattern: 6 reversals per second, contrast of 10% (activation of predominantly the magnocellular pathway); isoluminant, red-green stripe pattern: 83.3 milliseconds onset, 83.3 milliseconds offset, contrast of 30% and 80% (activation of predominantly the parvocellular pathway); and blue grating with yellow background adaptation: 200 milliseconds onset, 500 milliseconds offset (activation of the blue-sensitive pathway).
RESULTS: The glaucoma group and the control group differed significantly (P < 0.01) in the peak times of all chromatic VEP responses and to a lesser degree in the achromatic VEP. Considering the amplitudes, only the low-contrast red-green stimulus showed a statistically significant reduction in glaucoma. At a predefined specificity of 90%, in separating patients with glaucoma from healthy control subjects, the peak time of the blue-yellow VEP had a high sensitivity (90%), whereas the sensitivity of the achromatic VEP was low (31%). The red-green VEP showed a sensitivity of 73% using low contrast and 71% using high contrast. In a paired correlation analysis with visual field defects, all stimulations showed significant (P < 0.05) results. Correlation coefficients were highest (R = 0.79, P < 0.01) for the peak time of the blue-yellow VEP.
CONCLUSIONS: VEP measurements with presumable stimulation of single neuronal pathways can detect glaucomatous optic nerve damage in a considerable fraction of patients with visual field loss. Occipital responses to chromatic stimulation seem to be more sensitive to glaucoma damages than do responses to achromatic pattern reversal stimulation.

Entities:  

Mesh:

Year:  2000        PMID: 11131748     DOI: 10.1097/00061198-200012000-00003

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  11 in total

1.  Electrophysiological assessment of glaucomatous visual dysfunction during treatment with cytidine-5'-diphosphocholine (citicoline): a study of 8 years of follow-up.

Authors:  Vincenzo Parisi
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

2.  The effects of glaucoma on the latency of the multifocal visual evoked potential.

Authors:  S L Graham
Journal:  Br J Ophthalmol       Date:  2006-09       Impact factor: 4.638

3.  Development and validation of an associative model for the detection of glaucoma using pupillography.

Authors:  Dolly S Chang; Karun S Arora; Michael V Boland; Wasu Supakontanasan; David S Friedman
Journal:  Am J Ophthalmol       Date:  2013-09-04       Impact factor: 5.258

4.  Stereoscopic visual evoked potentials in normal subjects and patients with open-angle glaucomas.

Authors:  Antonio Bergua; Folkert K Horn; Peter Martus; Anselm M Jünemann; Matthias Korth
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-09       Impact factor: 3.117

5.  Color Doppler imaging and pattern visual evoked potential in normal tension glaucoma and hypertension glaucoma.

Authors:  Yisheng Zhong; Yingjun Min; Ying Jiang; Yu Cheng; Jiao Qin; Xi Shen
Journal:  Doc Ophthalmol       Date:  2009-09-12       Impact factor: 2.379

Review 6.  Significance of Visual Evoked Potentials in the Assessment of Visual Field Defects in Primary Open-Angle Glaucoma: A Review.

Authors:  Ruchi Kothari; Pradeep Bokariya; Smita Singh; Ramji Singh
Journal:  Neurosci J       Date:  2012-12-06

7.  The neuroprotective role of citicoline treatment in glaucoma - 6 months results of a prospective therapeutic trial.

Authors:  Iulia Chițu; Liliana-Mary Voinea; Sânziana Istrate; Alexandra Vrapciu; Radu Constantin Ciuluvică; Ruxandra Tudosescu
Journal:  Rom J Ophthalmol       Date:  2019 Jul-Sep

Review 8.  [The role of citicoline in glaucoma].

Authors:  Anselm G M Jünemann; P Grieb; R Rejdak
Journal:  Ophthalmologe       Date:  2021-03-17       Impact factor: 1.059

9.  Pattern Electroretinography and Visual Evoked Potentials Provide Clinical Evidence of CNS Modulation of High- and Low-Contrast VEP Latency in Glaucoma.

Authors:  William E Sponsel; Susan L Johnson; Rick Trevino; Alberto Gonzalez; Sylvia L Groth; Carolyn Majcher; Diane C Fulton; Matthew A Reilly
Journal:  Transl Vis Sci Technol       Date:  2017-11-08       Impact factor: 3.283

Review 10.  Visual evoked potential in the early diagnosis of glaucoma. Literature review.

Authors:  Anne Marie Firan; Sînziana Istrate; Raluca Iancu; Ruxandra Tudosescu; Radu Ciuluvică; Liliana Voinea
Journal:  Rom J Ophthalmol       Date:  2020 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.